CDC releases diabetes prevention program action guide for pharmacies
To encourage the pharmacy sector to take part in the nation's diabetes prevention program (DPP), CDC has issued a DPP implementation guide for pharmacists.
To encourage the pharmacy sector to take part in the nation's diabetes prevention program (DPP), CDC has issued a DPP implementation guide for pharmacists. The guide notes that participation in DPP allows pharmacies to expand their preventive care services as well as broaden their referral networks with primary care providers and community-based health care organizations. The program can be used in the ambulatory care setting "to maximize the unique skills and abilities of the pharmacy workforce," according to the guide. Tier 1 involves the promotion of awareness about prediabetes and the DPP program among those at-risk for diabetes, while Tier 2 activities include screening patients for prediabetes, testing when appropriate, and referring eligible patients to a supplier of DPP services. Tier 3 calls for offering DPP interventions to patients. As of late June, the CDC's DPP registry included 1,767 sites, the majority of which have pending or preliminary approval status. CMS has adopted its own Medicare DPP initiative based on the CDC's program that requires suppliers to apply to the CDC for recognition as part of the enrollment process.